According to this study, over the next five years the Anticoagulants market will register a 9.3% CAGR in terms of revenue, the global market size will reach $ 1237.2 million by 2025, from $ 865.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anticoagulants business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Anticoagulants market by type, application, key manufacturers and key regions and countries.

This study considers the Anticoagulants value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Platelet aggregation inhibitors (PAI)

Low-molecular-weight Heparin (LMWH)

Direct thrombin inhibitor (DTI)

Direct factor Xa inhibitors (DFXa)

Vitamin K antagonists (VKA)

Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

VTE

ACS/MI

AF

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Sanofi

Otsuka

Bayer

Johnson & Johnson

Genentech (Roche)

Boehringer Ingelheim

Aspen

AstraZeneca

Lilly

Bristol-Myers Squibb

Pfizer

The Medicines Company

Daiichi Sankyo

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Anticoagulants consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Anticoagulants market by identifying its various subsegments.

Focuses on the key global Anticoagulants manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Anticoagulants with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Anticoagulants submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anticoagulants Consumption 2015-2025

2.1.2 Anticoagulants Consumption CAGR by Region

2.2 Anticoagulants Segment by Type

2.2.1 Platelet aggregation inhibitors (PAI)

2.2.2 Low-molecular-weight Heparin (LMWH)

2.2.3 Direct thrombin inhibitor (DTI)

2.2.4 Direct factor Xa inhibitors (DFXa)

2.2.5 Vitamin K antagonists (VKA)

2.2.6 Others

2.3 Anticoagulants Consumption by Type

2.3.1 Global Anticoagulants Consumption Market Share by Type (2015-2020)

2.3.2 Global Anticoagulants Revenue and Market Share by Type (2015-2020)

2.3.3 Global Anticoagulants Sale Price by Type (2015-2020)

2.4 Anticoagulants Segment by Application

2.4.1 VTE

2.4.2 ACS/MI

2.4.3 AF

2.4.4 Other

2.5 Anticoagulants Consumption by Application

2.5.1 Global Anticoagulants Consumption Market Share by Type (2015-2020)

2.5.2 Global Anticoagulants Value and Market Share by Type (2015-2020)

2.5.3 Global Anticoagulants Sale Price by Type (2015-2020)

3 Global Anticoagulants by Company

3.1 Global Anticoagulants Sales Market Share by Company

3.1.1 Global Anticoagulants Sales by Company (2018-2020)

3.1.2 Global Anticoagulants Sales Market Share by Company (2018-2020)

3.2 Global Anticoagulants Revenue Market Share by Company

3.2.1 Global Anticoagulants Revenue by Company (2018-2020)

3.2.2 Global Anticoagulants Revenue Market Share by Company (2018-2020)

3.3 Global Anticoagulants Sale Price by Company

3.4 Global Anticoagulants Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Anticoagulants Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Anticoagulants Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Anticoagulants by Regions

4.1 Anticoagulants by Regions

4.2 Americas Anticoagulants Consumption Growth

4.3 APAC Anticoagulants Consumption Growth

4.4 Europe Anticoagulants Consumption Growth

4.5 Middle East & Africa Anticoagulants Consumption Growth

5 Americas

5.1 Americas Anticoagulants Consumption by Countries

5.1.1 Americas Anticoagulants Consumption by Countries (2015-2020)

5.1.2 Americas Anticoagulants Value by Countries (2015-2020)

5.2 Americas Anticoagulants Consumption by Type

5.3 Americas Anticoagulants Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Anticoagulants Consumption by Regions

6.1.1 APAC Anticoagulants Consumption by Regions (2015-2020)

6.1.2 APAC Anticoagulants Value by Regions (2015-2020)

6.2 APAC Anticoagulants Consumption by Type

6.3 APAC Anticoagulants Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Anticoagulants by Countries

7.1.1 Europe Anticoagulants Consumption by Countries (2015-2020)

7.1.2 Europe Anticoagulants Value by Countries (2015-2020)

7.2 Europe Anticoagulants Consumption by Type

7.3 Europe Anticoagulants Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Anticoagulants by Countries

8.1.1 Middle East & Africa Anticoagulants Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Anticoagulants Value by Countries (2015-2020)

8.2 Middle East & Africa Anticoagulants Consumption by Type

8.3 Middle East & Africa Anticoagulants Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Anticoagulants Distributors

10.3 Anticoagulants Customer

11 Global Anticoagulants Market Forecast

11.1 Global Anticoagulants Consumption Forecast (2021-2025)

11.2 Global Anticoagulants Forecast by Regions

11.2.1 Global Anticoagulants Forecast by Regions (2021-2025)

11.2.2 Global Anticoagulants Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Anticoagulants Forecast by Type

11.8 Global Anticoagulants Forecast by Application

12 Key Players Analysis

12.1 Sanofi

12.1.1 Company Information

12.1.2 Anticoagulants Product Offered

12.1.3 Sanofi Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Sanofi Latest Developments

12.2 Otsuka

12.2.1 Company Information

12.2.2 Anticoagulants Product Offered

12.2.3 Otsuka Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Otsuka Latest Developments

12.3 Bayer

12.3.1 Company Information

12.3.2 Anticoagulants Product Offered

12.3.3 Bayer Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Bayer Latest Developments

12.4 Johnson & Johnson

12.4.1 Company Information

12.4.2 Anticoagulants Product Offered

12.4.3 Johnson & Johnson Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Johnson & Johnson Latest Developments

12.5 Genentech (Roche)

12.5.1 Company Information

12.5.2 Anticoagulants Product Offered

12.5.3 Genentech (Roche) Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Genentech (Roche) Latest Developments

12.6 Boehringer Ingelheim

12.6.1 Company Information

12.6.2 Anticoagulants Product Offered

12.6.3 Boehringer Ingelheim Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Boehringer Ingelheim Latest Developments

12.7 Aspen

12.7.1 Company Information

12.7.2 Anticoagulants Product Offered

12.7.3 Aspen Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Aspen Latest Developments

12.8 AstraZeneca

12.8.1 Company Information

12.8.2 Anticoagulants Product Offered

12.8.3 AstraZeneca Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 AstraZeneca Latest Developments

12.9 Lilly

12.9.1 Company Information

12.9.2 Anticoagulants Product Offered

12.9.3 Lilly Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Lilly Latest Developments

12.10 Bristol-Myers Squibb

12.10.1 Company Information

12.10.2 Anticoagulants Product Offered

12.10.3 Bristol-Myers Squibb Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Bristol-Myers Squibb Latest Developments

12.11 Pfizer

12.11.1 Company Information

12.11.2 Anticoagulants Product Offered

12.11.3 Pfizer Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 Pfizer Latest Developments

12.12 The Medicines Company

12.12.1 Company Information

12.12.2 Anticoagulants Product Offered

12.12.3 The Medicines Company Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)

12.12.4 Main Business Overview

12.12.5 The Medicines Company Latest Developments

12.13 Daiichi Sankyo

12.13.1 Company Information

12.13.2 Anticoagulants Product Offered

12.13.3 Daiichi Sankyo Anticoagulants Sales, Revenue, Price and Gross Margin (2018-2020)

12.13.4 Main Business Overview

12.13.5 Daiichi Sankyo Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Anticoagulants Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Plat